InSilico offers consultancy services in computational drug discovery by field experts, using state-of-the-art algorithms. These consultancy services saves customers the need to purchase a variety of software products and to employ structural biologists on a regular basis.
| Website | http://www.insili.com |
| Revenue | $5.8 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2010 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Business Services General, Chemical, Business Services, Science and Engineering, Intellectual Property, Professional Services, Pharmaceutical, Health Care |
| Keywords | In Silico Drug Design, Computational Drug Discovery, Ai Drug Discovery, Drug Discovery Services, Computational Biology, Biotechnology Consulting, Precision Medicine Consulting, Pharmaceutical Consulting, Life Science Consulting, Drug Development Consulting |
| Competitors | Schrödinger, Recursion Pharmaceuticals, Insilico Medicine, Atomwise, BenevolentAI, CureMetrix, BioSymetrics, NuMedii +35 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Insilico Ltd employee's phone or email?
The Insilico Ltd annual revenue was $5.8 million in 2026.
The NAICS codes for Insilico Ltd are [541713, 54171, 54, 541, 5417].
The SIC codes for Insilico Ltd are [873, 87].